Opendata, web and dolomites

V.A. Cure SIGNED

A multidisciplinary approach towards sustainable improvement in rare diseases care uniting Europe's top class vascular research to find new treatment strategies for vascular anomalies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 V.A. Cure project word cloud

Explore the words cloud of the V.A. Cure project. It provides you a very rough idea of what is the project "V.A. Cure" about.

trained    interaction    network    confocal    biotech    perception    guarantee    group    industry    mosaic    multiphoton    disease    academic    leveraging    sequencing    rare    drug    editing    presentation    vessel    outreach    death    vas    technologies    mechanisms    assembled    maintenance    academia    medical    cure    graduates    pain    phage    leaders    clinical    training    highest    14    cutting    sudden    world    seq    light    blood    vitro    generation    lacking    aberrant    vivo    diseases    genome    esrs    establishing    combination    inducible    dissection    plethora    positions    vascular    core    dysfunction    cell    animal    pathophysiological    pharma    uncovering    lymph    models    secondments    close    media    therapeutic    sheet    initiation    function    writing    intersectoral    composition    tissular    imaging    crispr    candidates    treatment    outside    molecular    cas    edge    ipscs    companies    disabilities    genes    identification    competitive    anomalies    patients    live    rna    unmet    strategies    single    microfluidics    endothelial    chronic    causing    deletion    laboratories    gained    treatments    display    communication   

Project "V.A. Cure" data sheet

The following table provides information about the project.

Coordinator
DE DUVE INSTITUTE 

Organization address
address: AVENUE HIPPOCRATE 75
city: BRUXELLES
postcode: 1200
website: www.deduveinstitute.be

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Belgium [BE]
 Total cost 3˙792˙135 €
 EC max contribution 3˙792˙135 € (100%)
 Programme 1. H2020-EU.1.3.1. (Fostering new skills by means of excellent initial training of researchers)
 Code Call H2020-MSCA-ITN-2018
 Funding Scheme MSCA-ITN-ETN
 Starting year 2019
 Duration (year-month-day) from 2019-03-01   to  2023-02-28

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DE DUVE INSTITUTE BE (BRUXELLES) coordinator 512˙640.00
2    ASTRAZENECA AB SE (SODERTAELJE) participant 563˙965.00
3    UPPSALA UNIVERSITET SE (UPPSALA) participant 563˙965.00
4    INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE FR (PARIS) participant 549˙604.00
5    UNIVERSITAET POTSDAM DE (POTSDAM) participant 505˙576.00
6    KAROLINSKA INSTITUTET SE (STOCKHOLM) participant 281˙982.00
7    OULUN YLIOPISTO FI (OULU) participant 280˙805.00
8 SINGH PRATEEK FI participant 280˙805.00
9    MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV DE (MUENCHEN) participant 252˙788.00
10    TAMPEREEN YLIOPISTO FI (TAMPERE) participant 0.00
11    BAYER AKTIENGESELLSCHAFT DE (Leverkusen) partner 0.00
12    BELGIAN VASCULAR ANOMALY PATIENT ASSOCIATION BE (KRAAINEM) partner 0.00
13    CLINIQUES UNIVERSITAIRES SAINT-LUC BE (BRUXELLES) partner 0.00
14    LLS ROWIAK LASERLABSOLUTIONS GMBH DE (HANNOVER) partner 0.00
15    MOLECULINK AB SE (UPPSALA) partner 0.00
16    Perimed AB SE (Järfälla) partner 0.00
17    Sysmex Inostics GmbH DE (Hamburg) partner 0.00
18    TAMPEREEN KORKEAKOULUSAATIO SR FI (TAMPERE) partner 0.00

Map

 Project objective

Vascular anomalies (VAs) is a group of rare diseases defined by blood- or lymph vessel dysfunction causing chronic pain, disabilities, and even sudden death, and for which effective treatments are lacking. The European V.A. Cure network aims to address this unmet medical need by uncovering core mechanisms of disease initiation and maintenance and by leveraging this information for establishing novel therapeutic strategies for VAs. V.A. Cure has assembled 7 world-leading academic laboratories and 5 companies, which will apply an intersectoral four-step approach: (1) identification of novel genes involved in VAs in patients, (2) dissection of molecular mechanisms behind the diseases by in vitro modelling, (3) in-depth analysis of tissular mechanisms in pathophysiological conditions through in vivo models, and (4) pre-clinical testing of identified treatment strategies. The knowledge gained will not only be relevant for VAs but also for understanding aberrant vascular function in other vascular-related diseases. The composition of V.A. Cure and close interaction between the 14 ESRs, through secondments in academia and industry, guarantee a unique intersectoral training program at the highest level, ensuring a comprehensive perception of research and drug/technology development in pharma industry/biotech and academia. ESRs will be trained in a plethora of cutting-edge technologies including next-generation sequencing (up to single-cell RNA-Seq), CRISPR-Cas genome editing, generation of animal models with inducible deletion and mosaic analyses, generation of iPSCs, microfluidics, in vivo phage display to identify endothelial targets, and light sheet-, confocal-, and multiphoton live-imaging. In combination with advanced training in management and communication including writing, presentation, e-media and outreach, the graduates of the V.A. Cure network will be future leaders in vascular research, and also highly competitive candidates for positions outside academia.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "V.A. CURE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "V.A. CURE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.1.)

DISTINCT (2019)

Dementia: Intersectorial Strategy for Training and Innovation Network for Current Technology (DISTINCT)

Read More  

BIGMATH (2018)

Big Data Challenges for Mathematics

Read More  

POLISS (2019)

Policies for Smart Specialisation

Read More